Good MorningEquity markets advanced the previous week as economic and earnings trends lifted the market. The move was driven by better-than-expected results from NVIDIA and many retailers, including Walmart, Lowe's, and TJX Companies. The takeaway is that the consumer remains resilient, and the outlook for Q4 is likely low. The consensus is a low-single-digit increase in holiday quarter sales, sufficient to set a record.
Next week is a holiday-shortened week; the market is closed Thursday for Thanksgiving. The critical resistance point for the S&P 500 is near 6,100 and may be reached soon. A move above that level would signal a continuation of the market trends and a likelihood of a substantial gain in 2025. In that scenario, the S&P 500 could rise by another 1,300 basis points before topping out. Featured: What the Fed Isn’t Telling You About Digital Dollars (Ad) 
|
Tech | | |
The technology sector has been the focus of attention lately, with a special focus on the semiconductor industry and its biggest stories. Out of all the businesses centered in this space, two have commanded the most attention today, for good and bad reasons alike.
NVIDIA Co. (NASDAQ: NVDA) has be... Read the Full Story |
|
From Our Partners | | The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. | | Click here to see why the "End of Elon" crowd is about to be wrong again. |
|
Stocks | | | U.S. stocks rose Monday, with those benefiting the most from lower interest rates and a stronger economy leading the way.The S&P 500 climbed 0.3% to pull closer to its all-time high set two weeks ago. The Dow Jones Industrial Average added 440 points, or 1%, to its own record set on Friday, whil... Read the Full Story |
|
Markets | | |
Vertiv Holdings Co. (NYSE: VRT) has experienced a remarkable surge over the past year, but its stock price jumped approximately 15% in a single day following a well-received investor event. This significant price movement, coupled with a flurry of Vertiv Holding’s analyst community upgrades ... Read the Full Story |
|
From Our Partners | | On July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushing America’s debt-to-GDP ratio to 175%.
Top investors are warning of an epic bubble bursting soon. A free guide reveals how to shield your 401(k), savings, and portfolio before the collapse. | | Claim your FREE Big Beautiful Bubble Survival Guide now |
|
Tech | | |
Emerging market stocks can be particularly difficult to understand. However, there is evidence that those who do understand this part of the market can reap benefits. A 2023 study confirmed the belief that stock markets in developed countries are more efficient than those in emerging ones. This me... Read the Full Story |
|
Markets | | |
Tesla Inc. (NASDAQ: TSLA) stock has been up 56.2% since Donald Trump was elected president of the United States. But the recent move of 6.6% the week of November 18, 2024, has investors thinking that the stock may be going to $400 or even higher.
News broke that the Trump administration i... Read the Full Story |
|
From Our Partners | | Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. | | This little-known company holds nearly 100 patents and trades for around $7 |
|
Markets | | |
The Walt Disney Company (NYSE: DIS) needs little introduction. From its iconic animated films and beloved theme parks to its expansive television networks and quickly evolving streaming platforms, Disney holds a unique place in the global entertainment sector. Disney’s stock has seen a rec... Read the Full Story |
|
Markets | | | President-elect Donald Trump launched a blitz of picks for his Cabinet, but he took his time before settling on billionaire investor Scott Bessent as his treasury secretary nominee.The Republican not only wanted someone who jibes with him, but an official who can execute his economic vision and look... Read the Full Story |
|
Markets | | | Indian billionaire Gautam Adani, one of Asia’s richest men, may be facing his biggest challenge yet with an indictment by U.S. prosecutors for alleged fraud and bribery. But it’s unclear just how the case will affect his businesses and own future — as well as the Indian economy and government. On Fr... Read the Full Story |
|
Stocks | | | Donald Trump has big plans for the economy — and a big debt problem that will be a hurdle to delivering on them.Trump has bold ideas on tax cuts, tariffs and other programs, but high interest rates and the price of repaying the federal government’s existing debt could limit what he’s able to do.Not ... Read the Full Story |
|
Markets | | | Indigenous leaders from the Wampis Nation in Peru are urging lawmakers at the House of Commons in London to ban international banks’ support for Amazon oil activities they say harm their ancestral rainforests Read the Full Story |
|
Monday's Early Bird Stock Of The Day Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. | | View Today's Stock Pick |
|
